References
1. Alireza B,Behrooz H,Pauline H,Maryam M . Review of Toxoplasmic Encephalitis in HIV Infection; a Case Study;Archives of Neuroscience. 2015 April; 2(2): e20891.
2. Sreeramulu Diguvinti et al.Cerebral toxoplasmosis in HIV mimicking as primary CNS lymphoma/tuberculoma:case report.International Journal of Research in Health Sciences..Jul-Sept 2014;Issue-3.
3. Montoya JG,, Remington JS. Toxoplasma gondii. In: Mandell GL, Bennett JE, Dolin R, editor(s). Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone; 2000. p. 2858-2888.
4. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis. 1992;15(2):211-22.
5. Navia BA, Petito CK, Gold JW, Cho ES, Jordan BD, Price RW. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol. 1986;19(3):224-38.
6. Renold C, Sugar A, Chave JP, Perrin L, Delavelle J, Pizzolato G, et al. Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Medicine (Baltimore). 1992;71(4):224-39.
7. Gray F, Gherardi R, Wingate E, Wingate J, Fenelon G, Gaston A, et al. Diffuse "encephalitic" cerebral toxoplasmosis in AIDS. Report of four cases. J Neurol. 1989;236(5):273-7.
8. Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med. 1992;327(23):1643-8.
9. San-Andres FJ, Rubio R, Castilla J, Pulido F, Palao G, de Pedro I, et al. Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997. Clin Infect Dis. 2003;36(9):1177-85.
10. Levy RM, Janssen RS, Bush TJ, Rosenblum ML. Neuroepidemiology of acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr. 1988;1(1):31-40
11. Koppen S, Grunewald T, Jautzke G, Gottschalk J, Pohle HD, Ruf B. Prevention of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus infected patients: a clinical approach comparing aerosolized pentamidine and pyrimethamine/sulfad-oxine. Clin Investig. 1992;70(6):508-12.
12. Schurmann D, Bergmann F, Albrecht H, Padberg J, Wunsche T, Grunewald T, et al. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection. Eur J Clin Microbiol Infect Dis. 2002;21(5):353-61.
13. Kami kim, Lloyd H K. Toxoplasma infection: Harrison`s Principles Of Internal Medicine .19th Edition.2015;(253):1398-1405.